| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |